Genmab — September 2020

[E_L]

ok, thanks. and thanks to your colleague

[Plimsoller]

No problem. She is quite impressed that a Dutch guy who doesn't speak Chinese found that article

[Plimsoller]

[E_L]

haha

[Plimsoller]

Just elaborating after she had a second look. it says that the company got persmission from the government to perform the trials. It basically means that the company must have submitted the request to the government bureau beforehand.

[E_L]

i guess that makes sense. you can see in clinicaltrials that they are looking to add a lot of chinese hospitals in the trials, only the first PhI has some recruiting there
already

[Plimsoller]

Big market if they don't copy it

[E_L]

lol

[E_L]

the french estimate a maximum of 7,900 Dara patients in the SC reimbursement document
https://www.has-sante.fr/upload/docs/evamed/CT-18673_DARZALEX_PIC_INS_AvisDef_CT18673.pdf pdf p43

[GeorgeBest]

Freindly reminder: Fireside Chat with President and CEO, Jan van de Winkel and Executive Vice President and Chief Financial Officer, Anthony Pagano 17:45 https://morganstanley.webcasts.com/starthere.jsp?ei=1362465&tp_key=b7d3726cf5

[Solsen]

Horizon har sat ny ATH i dag... mon ikke Genmab også snart gør et forsøg

[gdn55]

Det kan vi da håbe på.

[Solsen]

Ser ud til man kan sende spørgsmål. PI er i front

[Solsen]

Hexa38 10-100 gange mere potent end dara. JNJ skal betale $150 for at overtage og 20% flat royalty. Var det virkelig doller ?

[nohope]

150$ ?Er det sådan et symbolsk beløb ?

[Solsen]

Mln - med Genmab regner man kun i millioner

[Solsen]

Tak

[nohope]

Ok, glæder mig til de går til kun at regne i MIA

[Solsen]

Much more potent than first line I/O - med PD-L1 x 4-1BB. Det lyder vildt !

[Solsen]

Til næste år regner vi i bn.